Steven Denbaars, Director at Akoustis Technologies, Inc. (AKTS), sold 7,000 shares at $3.57 ($25K) on 2022-12-06, disclosed to the SEC on 2022-12-08.
Scheduled sale ($25k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PrivatePalomino Laboratories Inc. | BUY | 2026-04-20 | $50K | — | Filing → |
| ALMU | SELL | 2026-02-27 | $418K | — | Filing → |
| ALMU | BUY | 2025-05-23 | $100K | — | Filing → |